5-Bromo-N-cyclopentylpicolinamide

Catalog No. :
ACYUSP819
CAS No. :
845305-91-1
Molecular Formula :
C11H13BrN2O
Molecular Weight :
269.14

IUPAC Name:5-bromo-N-cyclopentylpicolinamide

5-Bromo-N-cyclopentylpicolinamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$137.00Login to see priceInquiryInquiry
5g98%$371.00Login to see priceInquiryInquiry
10g98%$645.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-N-cyclopentylpicolinamide
IUPAC Name5-bromo-N-cyclopentylpicolinamide
MDL No.N186871
Molecular FormulaC11H13BrN2O
Molecular Weight269.14
SMILESO=C(NC1CCCC1)C2=NC=C(Br)C=C2
InChI KeyVZXHAPJVZJWCAR-UHFFFAOYSA-N
SynonymSCHEMBL20460546 | VIB30591 | 5-Bromo-N-cyclopentylpyridine-2-carboxamide | DTXSID10650070 | N-Cyclopentyl5-bromopicolinamide | A864105 | MFCD09801064 | CS-0205638 | N-Cyclopentyl 5-bromopicolinamide | AKOS012252169 | BS-23372 | 5-Bromo-N-cyclopentylpicoli
CAS No.845305-91-1
PubChem CID26370088

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACYUSP819 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBMRU705 route compound structure diagram
    ACBMRU70530766-11-1 In Stock
  4. Then
  5. ACYUSP819 route product structure diagram
    ACYUSP819845305-91-1
Inquiry

2. ACYUSP819 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGEOB735 route compound structure diagram
    ACGEOB735137178-88-2 In Stock
  4. Then
  5. ACYUSP819 route product structure diagram
    ACYUSP819845305-91-1
Inquiry

Comments (0)